Dario Health Corp. (NASDAQ:DRIO) is a leading digital therapeutics (DTx) company. One of the first Q4 Capital investment companies that went public on NASDAQ in April 2013.
A firm specializing in robotic machines that manufacture injectable drugs. Q4 Capital was one of the early investors in VanRx that shortly after became one of the fastest growing tech companies in Canada. In January 2021, VanRx was acquired by Cytiva.
Q4 Capital funded Big Blue Bubble's growth phase. After winning numerous business and product awards, Big Blue Bubble was acquired by EG7 (STO: EG7 ) in November 2020.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.